Related Experiment Video
Updated: Jul 23, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
A statistical model for functional mapping of quantitative trait loci regulating drug response
The Pharmacogenomics Journal
|July 21, 2004
Summary
This study introduces a new statistical model for genetic mapping of quantitative trait loci (QTL) influencing drug response. The model integrates functional and linkage disequilibrium mapping for precise identification of genes affecting pharmacodynamics.
Area of Science:
- Pharmacogenetics
- Statistical Genetics
- Genomics
Background:
- Differential drug response (pharmacodynamics) is a complex trait influenced by multiple genes and environmental factors.
- Genetic mapping, particularly quantitative trait loci (QTL) analysis, is crucial for identifying genes underlying complex traits.
- Existing methods may lack the resolution or functional integration needed for comprehensive pharmacodynamic trait analysis.
Purpose of the Study:
- To present a novel statistical model for the high-resolution genetic mapping of QTL that govern pharmacodynamic processes.
- To integrate functional mapping and linkage disequilibrium mapping for improved QTL detection in pharmacodynamics.
- To provide a robust framework for analyzing complex drug responses influenced by genetic variations.
Main Methods:
- Developed a hybrid statistical model combining functional mapping and linkage disequilibrium mapping.
- Implemented an Expectation-Maximization algorithm with a closed-form solution for estimating QTL genetic parameters.
- Utilized the simplex algorithm for estimating curve parameters of pharmacodynamic changes across different QTL genotypes.
Main Results:
- The novel model successfully integrates functional and linkage disequilibrium mapping approaches.
- Simulation studies demonstrated favorable statistical properties of the proposed model.
- The model allows for precise estimation of genetic parameters and pharmacodynamic response curves.
Conclusions:
- The developed model offers a powerful tool for genetic mapping of pharmacodynamic traits.
- This approach enhances the understanding of genetic influences on differential drug responses.
- The model has significant implications for advancing pharmacogenetic and pharmacogenomic research.
Related Concept Videos
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...